Carmelo Scarpignato

Carmelo Scarpignato's AcademicInfluence.com Rankings

Carmelo Scarpignato

Philosophy

#8334

World Rank

#11691

Historical Rank

Logic

#5367

World Rank

#6760

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Carmelo Scarpignato Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Carmelo Scarpignato's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Myths and Misconceptions About Chronic Constipation (2005) (476)
The burden of constipation on quality of life: results of a multinational survey (2007) (313)
Caustic injury of the upper gastrointestinal tract: a comprehensive review. (2013) (299)
Effective and safe proton pump inhibitor therapy in acid-related diseases – A position paper addressing benefits and potential harms of acid suppression (2016) (268)
Effective and safe proton pump inhibitor therapy in acid-related diseases – A position paper addressing benefits and potential harms of acid suppression (2016) (268)
Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy (2013) (265)
Mechanisms of Damage to the Gastrointestinal Tract From Nonsteroidal Anti-Inflammatory Drugs. (2017) (260)
Reflux related symptoms in patients with normal oesophageal exposure to acid. (1995) (254)
A multinational survey of prevalence and patterns of laxative use among adults with self‐defined constipation (2008) (229)
Rifaximin, a Poorly Absorbed Antibiotic: Pharmacology and Clinical Potential (2005) (215)
Nonsteroidal antiinflammatory drug-related injury to the gastrointestinal tract: clinical picture, pathogenesis, and prevention. (2010) (202)
Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis – an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risks (2015) (176)
Proton pump inhibitors in GORD An overview of their pharmacology, efficacy and safety. (2009) (159)
Action of caerulein on gastric emptying of the conscious rat. (1980) (145)
Italian consensus conference for colonic diverticulosis and diverticular disease (2014) (144)
Systematic review with meta‐analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth (2017) (136)
Experimental and Clinical Pharmacology of Rifaximin, a Gastrointestinal Selective Antibiotic (2006) (118)
Endogenous cholecystokinin in postprandial lower esophageal sphincter function and fundic tone in humans. (1998) (109)
Acid Suppression Therapy: Where Do We Go from Here? (2006) (100)
DNA/protein flow cytometry as a predictive marker of malignancy in dysplasia-free Barrett's esophagus: thirteen-year follow-up study on a cohort of patients. (1998) (94)
Oesophageal corrosive injuries in children: a forgotten social and health challenge in developing countries. (2009) (91)
Microbial Flora in NSAID-Induced Intestinal Damage: A Role for Antibiotics? (2006) (86)
Somatostatin Analogs for Cancer Treatment and Diagnosis: An Overview (2001) (86)
The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel (2010) (80)
Proton pump inhibitors: the beginning of the end or the end of the beginning? (2008) (79)
Determinants of the short‐term gastric damage caused by NSAIDs in man (2007) (76)
‘Rescue’ Therapies for the Management of Helicobacter pylori Infection (2006) (70)
Management of irritable bowel syndrome: novel approaches to the pharmacology of gut motility. (1999) (70)
COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist (2020) (67)
Treatment of gastro-oesophageal reflux disease in adults (1998) (67)
Potassium-Competitive Acid Blockers (P-CABs): Are They Finally Ready for Prime Time in Acid-Related Disease? (2015) (59)
Inhibition of acetylcholine induced intestinal motility by interleukin 1 beta in the rat. (1996) (58)
Multimodal analgesia in moderate-to-severe pain: a role for a new fixed combination of dexketoprofen and tramadol (2017) (58)
Hepatic encephalopathy 2018: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF). (2019) (57)
Nonsteroidal anti-inflammatory drugs: how do they damage gastroduodenal mucosa? (1995) (56)
Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non‐erosive reflux disease – efficacy of Esoxx, a hyaluronic acid–chondroitin sulphate based bioadhesive formulation (2017) (54)
NSAID-induced intestinal damage: are luminal bacteria the therapeutic target? (2008) (54)
Effect of CCK and its antagonists on gastric emptying (1993) (52)
Colonic diverticular disease (2020) (51)
Rifaximin Reduces the Number and Severity of Intestinal Lesions Associated With Use of Nonsteroidal Anti-Inflammatory Drugs in Humans. (2017) (51)
Myths and facts in the use of anti-inflammatory drugs (2009) (51)
HISTAMINE H2‐ANTAGONISTS MODIFY GASTRIC EMPTYING IN THE RAT (1982) (50)
In vitro contractile effects of short chain fatty acids in the rat terminal ileum. (1996) (48)
Specific adaptation of gastric emptying to diets with differing protein content in the rat: is endogenous cholecystokinin implicated? (1997) (47)
Mesalazine for the Treatment of Symptomatic Uncomplicated Diverticular Disease of the Colon and for Primary Prevention of Diverticulitis: A Systematic Review of Randomized Clinical Trials (2016) (45)
Corrosive oesophageal strictures in children: outcomes after timely or delayed dilatation. (2009) (45)
Poor effectiveness of proton pump inhibitors in non‐erosive reflux disease: the truth in the end! (2012) (43)
Impact of primary antibiotic resistance on the effectiveness of sequential therapy for Helicobacter pylori infection: lessons from a 5‐year study on a large number of strains (2018) (42)
NSAID-Induced Enteropathy: Are the Currently Available Selective COX-2 Inhibitors All the Same? (2014) (41)
Review article: the opportunities and benefits of extended acid suppression (2006) (41)
Bombesin delays gastric emptying in the rat. (1981) (40)
Prevention and Treatment of Traveler's Diarrhea: A Clinical Pharmacological Approach (Part 1 of 2) (1995) (40)
Corrosive esophageal injuries in children. A shortlived experience in Sierra Leone. (2007) (40)
Somatostatin for Upper Gastrointestinal Hemorrhage and Pancreatic Surgery (1999) (40)
Piroxicam-β-Cyclodextrin: A GI Safer Piroxicam (2013) (39)
Involvement of the P2X7 Purinergic Receptor in Colonic Motor Dysfunction Associated with Bowel Inflammation in Rats (2014) (39)
Gastric Emptying Measurement in Man (1990) (39)
Risk of gastrointestinal complications associated to NSAIDs, low-dose aspirin and their combinations: Results of a pharmacovigilance reporting system. (2016) (39)
Management of colonic diverticular disease in the third millennium: Highlights from a symposium held during the United European Gastroenterology Week 2017 (2018) (39)
Predictive value of the Diverticular Inflammation and Complication Assessment (DICA) endoscopic classification on the outcome of diverticular disease of the colon: An international study (2016) (38)
Towards an Effective and Safe Treatment of Inflammatory Pain: A Delphi-Guided Expert Consensus (2019) (37)
Effect of dexloxiglumide and spiroglumide, two new CCK‐receptor antagonists, on gastric emptying and secretion in the rat: evaluation of their receptor selectivity in vivo. (1996) (37)
Oxygen free radicals interact with indomethacin to cause gastrointestinal injury (1986) (36)
Development and Validation of an Endoscopic Classification of Diverticular Disease of the Colon: The DICA Classification (2014) (36)
Revisiting Montreal: New Insights into Symptoms and Their Causes, and Implications for the Future of GERD (2018) (36)
Clinical pharmacology and safety profile of esomeprazole, the first enantiomerically pure proton pump inhibitor. (2001) (35)
Effect of a new potent CCK antagonist, lorglumide, on caerulein‐ and bombesin‐induced pancreatic secretion and growth in the rat (1989) (34)
Can Gangrenous Cholecystitis be Prevented?: A Plea Against a “Wait and See” Attitude (2004) (34)
Long acting release-octreotide as "rescue" therapy to control angiodysplasia bleeding: A retrospective study of 98 cases. (2014) (33)
Potent Acid Suppression with PPIs and P-CABs: What’s New? (2018) (32)
Rifaximin in the management of colonic diverticular disease (2009) (32)
Management of Colonic Diverticular Disease (2006) (31)
Pathophysiology of NSAID-Associated Intestinal Lesions in the Rat: Luminal Bacteria and Mucosal Inflammation as Targets for Prevention (2018) (31)
Is generic rifaximin still a poorly absorbed antibiotic? A comparison of branded and generic formulations in healthy volunteers. (2014) (31)
Impact of crystal polymorphism on the systemic bioavailability of rifaximin, an antibiotic acting locally in the gastrointestinal tract, in healthy volunteers (2014) (30)
Quality of life for patients with gastroesophageal reflux disease 2 years after laparoscopic fundoplication (2002) (30)
Role of the A2B receptor–adenosine deaminase complex in colonic dysmotility associated with bowel inflammation in rats (2014) (28)
Drug-Induced Small Bowel Injury: a Challenging and Often Forgotten Clinical Condition (2019) (28)
Small bowel protection against NSAID-injury in rats: Effect of rifaximin, a poorly absorbed, GI targeted, antibiotic. (2016) (27)
Colonic motor dysfunctions in a mouse model of high-fat diet-induced obesity: an involvement of A2B adenosine receptors (2017) (26)
Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds. (1999) (26)
EFFECT OF SUBSTANCE P AND ITS NATURAL ANALOGUES ON GASTRIC EMPTYING OF THE CONSCIOUS RAT (1981) (26)
Ranitidine delays gastric emptying of solids in man. (1982) (25)
Inhibition of gastric emptying by bombesin in man. (1982) (25)
Octreotide : from basic science to clinical medicine (1996) (25)
Management of Patients With Diverticulosis and Diverticular Disease: Consensus Statements From the 2nd International Symposium on Diverticular Disease (2016) (25)
Current trends in the management of achalasia. (2001) (25)
Does BMI affect the clinical efficacy of proton pump inhibitor therapy in GERD? The case for rabeprazole (2011) (24)
Gastric cancer prevention targeted on risk assessment: Gastritis OLGA staging (2019) (23)
Efficacy and safety of piroxicam revisited. A global meta-analysis of randomised clinical trials. (2009) (23)
Long-term treatment with mesalazine in patients with symptomatic uncomplicated diverticular disease (2012) (23)
Endoscopic treatment of gastro-oesophageal reflux disease (GORD): a systematic review. (2003) (22)
Towards the ideal regimen for Helicobacter pylori eradication: the search continues. (2004) (22)
Quantification of serum levels of pepsinogens and gastrin to assess eradication of Helicobacter pylori. (2011) (22)
Features and management of esophageal corrosive lesions in children in Sierra Leone: lessons learned from 175 consecutive patients. (2011) (21)
Rifaximin, a Peculiar Rifamycin Derivative: Established and Potential Clinical Use Outside the Gastrointestinal Tract (2005) (21)
Eradication of Helicobacter pylori: Are Rifaximin-Based Regimens Effective? (2006) (21)
Different actions of CCK on pancreatic and gastric growth in the rat: effect of CCKA receptor blockade (1998) (20)
International Consensus on Diverticulosis and Diverticular Disease. Statements from the 3rd International Symposium on Diverticular Disease. (2020) (20)
The potential role of potassium-competitive acid blockers in the treatment of gastroesophageal reflux disease. (2019) (20)
Antisecretory and antiulcer effect of the H2‐receptor antagonist famotidine in the rat: comparison with ranitidine (1987) (20)
Floating modular drug delivery systems with buoyancy independent of release mechanisms to sustain amoxicillin and clarithromycin intra-gastric concentrations (2016) (20)
Camostate- and caerulein-induced delay of gastric emptying in the rat: effect of CCK receptor antagonists. (1996) (20)
Distinct receptors mediate gastrin-releasing peptide and neuromedin B-induced delay of gastric emptying of liquids in rats (1995) (19)
The place of octreotide in the medical management of the dumping syndrome. (1996) (19)
Prevention and treatment of traveler's diarrhea: a clinical pharmacological approach. (1995) (18)
Oesophageal sensitivity to acid in patients with non-cardiac chest pain: is the oesophagus hypersensitive? (1995) (18)
Inhibition of gastric acid secretion by adenosine receptor stimulation in the rat. (1987) (18)
Clinical investigation of gastric function (1990) (18)
Eosinophilic Esophagitis: Diagnosis and Current Management. (2020) (18)
Treatment of Functional Bowel Disorders: Is There Room for Antibiotics? (2006) (18)
Cimetropium bromide, a new antispasmodic compound: pharmacology and therapeutic perspectives. (1985) (17)
Somatostatin Analogues in the Management of Endocrine Tumors of the Pancreas (1994) (17)
Effect of ranitidine and cimetidine on gastric emptying of a mixed meal in man. (1984) (17)
Interplay between colonic inflammation and tachykininergic pathways in the onset of colonic dysmotility in a mouse model of diet-induced obesity (2018) (17)
Antisecretory Drugs for Eradication of Helicobacter pylori: Antibacterial Activity and Synergism with Antimicrobial Agents (1999) (17)
New therapeutic approaches for management of sport-induced muscle strains (2009) (17)
Inhibition of gastric emptying and secretion by pirenzepine and atropine in rats. (1984) (16)
Expert Consensus on Clinical Use of an Orally Administered Dexketoprofen Plus Tramadol Fixed-Dose Combination in Moderate-To-Severe Acute Pain: A Delphi Study (2019) (16)
Pharmacological stimulation of gastrointestinal motility: where we are and where are we going? (1997) (16)
Effect of bombesin on basal and stimulated secretion of some pituitary hormones in humans. (1986) (16)
Effect of bombesin and its mammalian counterpart, GRP, on exocrine pancreas in the rat. (1988) (15)
Current Management of Patients With Diverticulosis and Diverticular Disease: A Survey From the 2nd International Symposium on Diverticular Disease (2016) (15)
Gastrointestinal safety of amtolmetin guacyl in comparison with celecoxib in patients with rheumatoid arthritis. (2005) (15)
Prokinetics in the treatment of gastro-oesophageal reflux disease. International symposium. Paris, France, 5 September 1996. (1998) (15)
The effect of bombesin on gastric emptying of solids in man (1981) (15)
Bismuth Compounds for Eradication of Helicobacter pylori: Pharmacology and Safety (1999) (15)
Gastric Emptying in Gastroesophageal Reflux Disease and Other Functional Esophageal Disorders (1994) (15)
Dysphagia and Clinical Outcome after Laparoscopic Nissen or Rossetti Fundoplication: Sequential Prospective Study (2002) (15)
Transmucosal potential difference as an index of esophageal mucosal integrity. (1995) (15)
Editorial: towards extended acid suppression – the search continues (2015) (14)
Management of perforated diverticulitis with generalized peritonitis. A multidisciplinary review and position paper (2020) (14)
Nonsteroidal Anti-Inflammatory Drug-Activated Gene-1 Plays a Role in the Impairing Effects of Cyclooxygenase Inhibitors on Gastric Ulcer Healing (2012) (14)
Dysphagia aortica: a neglected symptom of aortoesophageal fistula. (2006) (14)
Commentary: towards an effective and safe treatment of small intestine bacterial overgrowth (2013) (14)
Caerulein delays gastric emptying of solids in man. (1981) (14)
Cholecystokinin Antagonists and Motilides: Pharmacology and Potential in the Treatment of Gastroesophageal Reflux Disease and Other Digestive Motor Disorders (1992) (13)
The effect of the new H2-receptor antagonist mifentidine on gastric secretion, gastric emptying and experimental gastric and duodenal ulcers in the rat: comparison with cimetidine and ranitidine. (1986) (13)
Quality of life for patients with gastroesophageal reflux disease 2 years after laparoscopic fundoplication. Evaluation of the results obtained during the initial experience. (2002) (13)
Short-term versus long-term cefuroxime prophylaxis in patients undergoing emergency cesarean section. (1982) (13)
A new technique for continuous measurement and recording of gastric potential difference in the rat: evaluation of NSAID-induced gastric mucosal damage. (1995) (13)
Esomeprazole immediate release tablets: Gastric mucosa ex vivo permeation, absorption and antisecretory activity in conscious rats. (2016) (13)
Pharmacological bases of the medical treatment of gastroesophageal reflux disease. (1988) (13)
Modern diagnosis of gastroesophageal reflux disease (GERD). (1998) (13)
Effects of alkyl analogues of histamine and metiamide on the isolated guinea pig heart. (1981) (13)
Searching for a definition for pharmacologically refractory constipation: A systematic review (2018) (13)
Different effects of atropine and cimetropium bromide on gastric emptying of liquids and antroduodenal motor activity in man. (1990) (12)
Different effects of cimetidine and ranitidine on gastric emptying in rats and man (1982) (12)
Potential proton pump inhibitor–related adverse effects (2020) (12)
Effect of histamine and related compounds on gastric emptying of the conscious rat. (1981) (12)
Helicobacter pylori eradication: are we really all equal? A controlled study in native and immigrant population (2011) (12)
Does the learning phase influence the late outcome of patients with gastroesophageal reflux disease after laparoscopic fundoplication? (2004) (11)
Editorial: potassium‐competitive acid blockers for acid‐related diseases—tegoprazan, a new kid on the block (2019) (11)
Advances in drug therapy of gastroesophageal reflux disease (1992) (11)
Pharmacologic treatment of GERD: Where we are now, and where are we going? (2020) (11)
Combined Treatment with Polynucleotides and Hyaluronic Acid Improves Tissue Repair in Experimental Colitis (2020) (11)
Bombesin inhibits growth hormone response to insulin-induced hypoglycemia in humans (1986) (10)
Antisecretory drugs, Helicobacter pylori infection and symptom relief in GORD: still an unexplored triangle. (2005) (10)
New drugs to suppress acid secretion: current and future developments (2007) (10)
Probiotics for the Treatment of Symptomatic Uncomplicated Diverticular Disease: Rationale and Current Evidence. (2016) (9)
Colonic Dysmotility Associated with High Fat Diet-Induced Obesity: Role of the Enteric Glia (2017) (9)
Antacids and Alginates in the Treatment of Gastroesophageal Reflux Disease: How Do They Work and How Much Are They Clinically Useful? (1992) (9)
Inhibition of pancreatic secretory and trophic response to caerulein by the H2-receptor antagonist ranitidine in the rat. (1985) (9)
Barrett's esophagus: proton pump inhibitors and chemoprevention II (2011) (9)
Rifaximin: a poorly absorbed antibiotic, pharmacology and clinical use. (2005) (9)
Antiemetic Drug Use in Children: What the Clinician Needs to Know (2019) (9)
Intermittent versus every-day mesalazine therapy in preventing complications of diverticular disease: a long-term follow-up study. (2013) (9)
Benign and precursor lesions in the esophagus (2014) (8)
Symptomatic Uncomplicated Diverticular Disease: Chronic Abdominal Pain in Diverticulosis Is Not Enough to Make the Diagnosis. (2018) (8)
Effect of the new H2-receptor antagonist mifentidine on gastric acid secretion in the cat: comparison with cimetidine and ranitidine. (1985) (8)
An expert consensus definition of failure of a treatment to provide adequate relief (F‐PAR) for chronic constipation – an international Delphi survey (2017) (8)
Evaluation of Clinical Outcome after Laparoscopic Antireflux Surgery in Clinical Practice: Still a Controversial Issue (2011) (8)
Octreotide, the Synthetic Long-Acting Somatostatin Analogue: Pharmacological Profile (1996) (8)
Early esophageal transit study after laparoscopic fundoplication: how useful is it? (2002) (8)
A Population Pharmacokinetic Model of Vonoprazan: Evaluating the Effects of Race, Disease Status, and Other Covariates on Exposure (2021) (7)
Acid Suppressant Therapy: a Step Forward with Potassium-Competitive Acid Blockers (2021) (7)
Caerulein in supramaximal doses fails to stimulate pancreatic growth, but it forces secretory granulopoiesis. (1988) (7)
Commentary: towards a cardiac safe prokinetic (2012) (7)
Comparative efficacy of two different regimens of antibiotic prophylaxis in total abdominal hysterectomy. (1980) (7)
Inhibition of the histamine-stimulated adenylate cyclase activity of guinea pig gastric cells by the H2-receptor antagonists cimetidine, oxmetidine and SKF 93479. (1984) (7)
Prognostic Role of the Endoscopic Classification “DICA” (2016) (7)
Endogenous cholecystokinin in postprandial lower esophageal sphincter function and fundic tone in humans. (1998) (7)
Effect of acute and chronic cimetidine administration on glucose tolerance and insulin secretion in man. (1981) (7)
Effect of cimetropium bromide and other antispasmodic compounds on in vitro guinea-pig gallbladder. (1989) (7)
Editorial: healing of refractory reflux oesophagitis – an ongoing unmet clinical need (2014) (6)
Editorial: hyponatremia – a possible but forgotten consequence of bowel preparation for colonoscopy (2014) (6)
Different effects of the H2-antagonists on gastric emptying in the rat (1982) (6)
Safety Profile of Octreotide (1996) (6)
Different affinity states of CCK1 receptors on pancreatic acini and gastric smooth muscle in the rat (2001) (6)
The "DICA" endoscopic classification for diverticular disease of the colon shows a significant interobserver agreement among community endoscopists. (2019) (6)
Effects of cimetidine on the secretion of some pituitary hormones. (1979) (6)
Gastrointestinal pharmacology: practical tips for the esophagologist (2020) (6)
Clinical pharmacology of active variceal bleeding. (1992) (6)
Tu1181 Intermittent Versus Every-Day Mesalazine Therapy in Preventing Complications of Diverticular Disease: A Long-Term Follow-up Study (2013) (6)
Caustic ingestion in children: is endoscopy always indicated? A perspective from a Sierra Leone experience. (2009) (5)
Sucralfate and Other Mucosal Protective Compounds: Pharmacology and Potential in the Treatment of Esophageal Lesions (1992) (5)
[Gastric emptying of solids in gastroesophageal reflux]. (1986) (5)
Improving opportunities for effective management of gastro-oesophageal reflux disease. (2001) (5)
Action of MDL 646, a new synthetic prostaglandin, on gastric acid secretion of some experimental animals. (1983) (5)
Simultaneous measurement and recording of gastric potential difference and intragastric pH in man. (1990) (5)
New therapeutic modalities for benign oesophageal disease: an overview. (2001) (4)
Effect of a new CCK-A receptor antagonist, dexloxiglumide, on the exocrine pancreas in the rat (1997) (4)
Rifaximin for the management of colonic diverticular disease: far beyond a simple antibiotic. (2018) (4)
Editorial: adequate management may reduce the colorectal cancer risk associated with constipation (2014) (4)
Mo1135 Gastrin 17 As Non Invasive Marker of Reflux Disease (2015) (4)
M1805 Defining, Diagnosing and Treating Constipation: Attitudes Among Gastroenterologists and General Practitioners - Results of a Three Country Survey (2008) (4)
Functional investigation of esophageal disease (1994) (4)
Dual effect of bombesin and gastrin releasing peptide on gastric emptying in conscious cats (1989) (4)
Acid Suppression for Management of Gastroesophageal Reflux Disease: Benefits and Risks (2018) (4)
PANCREATIC SECRETORY AND TROPHIC RESPONSE TO CAERULEIN IN RATS: EFFECT OF PROGLUMIDE AND LORGLUMIDE (1989) (4)
Editorial: acid suppression with potassium‐competitive acid blockers dismissing genotype concerns (2021) (4)
The effect of ranitidine on exocrine pancreatic secretion in the rat. (1985) (4)
Use of Antisecretory Medication after Antireflux Surgery for Patients with Gastroesophageal Reflux Disease (GERD): A Systematic Review of Randomized Control Trials (RCTs): 59 (2009) (4)
Cimetidine inhibition of dimaprit-induced writhing in the rat. (1986) (4)
Somatostatin in Digestive Diseases: Improving the Treatment Options (1999) (4)
Neurotransmitters involved in the mechanical response of guinea pig gallbladder to electrical field stimulation (1997) (4)
Clinical pharmacology and therapy of Helicobacter pylori infection (1999) (4)
Adherence with regulatory resolutions on prevention of NSAIDs-related gastrointestinal injury in Italy (2016) (4)
Mo2055 Rifaximin for Treatment of Small Intestine Bacterial Overgrowth (SIBO): A Systematic Review and Meta-Analysis (2013) (4)
Prolactin response to TRH after intravenous cimetidine. (1979) (3)
Comparative effects of vasoactive intestinal peptide and secretin on exocrine pancreatic secretion in the cat (1985) (3)
Effect of loxiglumide on lower esophageal sphincter motor events and gastric relaxation induced by duodenal infusion of a liquid meal in healthy subjects (1998) (3)
Comparing tapentadol to oxycodone/naloxone combination: building castles in the air (2015) (3)
Renal removal of glucagon and insulin after acute hepatic ischaemia in dogs. (1983) (3)
Relaxant effect of the H2‐receptor antagonist oxmetidine on guinea‐pig and human airways (1987) (3)
Poor effectiveness of PPIs in Non‐Erosive Reflux Disease: the truth in the end! (2013) (3)
Hot Topics in Medical Treatment of Diverticular Disease: Evidence Pro and Cons. (2020) (3)
Natural History of Symptomatic Uncomplicated Diverticular Disease: A 13-Year Prospective Study (2017) (3)
P.09.1 RECOVERY OF GASTRIC FUNCTION AFTER HELICOBACTER PYLORI ERADICATION AND ACETIUM ADMINISTRATION: A 6 YEARS STUDY IN ATROPHIC GASTRITIS SUBJECTS (2013) (3)
Bombesin-induced pancreatic secretion and growth in rats: effect of proglumide, spantide and ranitidine. (1990) (3)
Effect of famotidine and ranitidine on gastric secretion and emptying in the rat (1987) (3)
[A simple method for the measurement of human gastric emptying: standardization of operative parameters]. (1983) (3)
Effect of TRH on pentagastrin-induced gastric acid secretion. (1981) (3)
Use of Pharmacogenetics to Optimize Immunosuppressant Therapy in Kidney-Transplanted Patients (2022) (3)
Letter: can the overall gastrointestinal safety of celecoxib be extended to all COX‐2‐selective agents? (2018) (3)
Usefulness of Serum Pepsinogens to Identify Chronic Atrophic Gastritis (2011) (3)
Editorial: Helicobacter pylori resistance and sequential therapy—authors’ reply (2018) (3)
Su2069 How Effective Is Prucalopride for the Treatment of Chronic Constipation? A Systematic Review and Meta-Analysis (2013) (3)
Different effects of bombesin on glucose‐ and tolbutamide‐induced insulin release in man (1988) (3)
Rifaximin prevents enteric bacteria alterations and inflammation in a rat model of diclofenac-induced enteropathy (2015) (3)
Subject Index, Vol. 15, 1981 (1981) (3)
PWE-079 Use of antisecretory medication after antireflux surgery for patients with gastro-oesophageal reflux disease: a systematic review of non-randomised studies (2010) (2)
Review article: rethinking the “ladder” approach to reflux‐like symptom management in the era of PPI “resistance” ‐ a multidisciplinary perspective (2022) (2)
P.06.20 GERD DIAGNOSIS IN 340 PATIENTS WITH ATYPICAL OR EXTRA-ESOPHAGEAL SYMPTOMS BY USING A NON INVASIVE SURROGATE TEST (2018) (2)
Publisher Correction: Colonic diverticular disease (2020) (2)
[Nitric monoxide (NO), mediator of non-adrenergic non-cholinergic effects of the enteric nervous system and esophago-gastric motility]. (1995) (2)
S1368 Vonoprazan-Based Dual Therapy and FDA-Approved H. pylori Eradication Regimens: A Comparison of the Available Pooled Data (2020) (2)
[Functional endoscopy : the physiological and pathophysiological basis of reflux disease, diagnosis and therapy]. (2009) (2)
[Short- or long-term antibiotic prophylaxis in obstetric and gynecologic laparotomy?]. (1984) (2)
Columnar‐lined (Barrett's) esophagus (1990) (2)
Inhibition of caerulein-induced gall bladder emptying by cimetropium bromide in humans (2004) (2)
The DICA Endoscopic Classification for Diverticular Disease of the Colon Shows a Significant Interobserver Agreement among Community Endoscopists: an International Study. (2020) (2)
Diagnosis and Treatment of Colonic Diverticular Disease: Position Paper of the Romanian Society of Gastroenterology and Hepatology. (2018) (2)
Metoclopramide: Is There Still a Place in the Treatment of Gastroesophageal Reflux Disease? (1992) (2)
Adverse Effects of Nonsteroidal Anti-inflammatory Drugs on the Cardiovascular System (2016) (2)
Effect of caerulein on pituitary response to TRH in humans. (1986) (2)
Eosinophilic esophagitis: updates on key unanswered questions (2020) (2)
Addressing long-term PPI safety. (2020) (2)
Are H2-receptors involved in the physiological regulation of gastric emptying? (1987) (2)
Mo1875 Is H. pylori Eradication Useful in the Improvement of Dyspepsia?: A 15 Years Study (2013) (2)
Distinct receptors mediate gastrin-releasing peptide and neuromedin beta-induced delay of gastric of liquids in rats. (1995) (2)
Sa1907 Sequential Therapy for Eradication of Helicobacter pylori Infection in Adults: Still Far From the Ideal Treatment. A Systematic Review and Meta-Analysis (2013) (2)
Chapter 36 - Gastrointestinal Drugs (2014) (2)
36 - Gastrointestinal drugs (2012) (2)
Advances in GI Pharmacology and Therapeutics (2006) (2)
Prevention and Treatment of Traveler's Diarrhea: A Clinical Pharmacological Approach (Part 2 of 2) (1995) (2)
Gastrin 17 in Singling Out Patients with Different Patterns of Refluxate: A Pilot Study Using Impedance-pH as Reference Standard (2017) (2)
Bacterial flora in digestive disease : focus on rifaximin (2006) (2)
Mucosal protective agents: why forget pirenzepine? (1988) (2)
Critical Issues in Bioequivalence and Inference on Therapeutic Equivalence (2014) (2)
Bombesin promotes pancreatic growth in suckling rats (1987) (2)
Effect of devazepide on caerulein and camostate induced delay of gastric emptying in the rat (1992) (2)
Bombesin and gastric emptying. (1984) (2)
Sa1906 Sequential Therapy for Eradication of Helicobacter pylori Infection in Children: A Systematic Review and Meta-Analysis (2013) (1)
Effect of cisapride on gastric emptying of solids and postprandial esophageal exposure to acid in healthy volunteers (1992) (1)
Recovery of Gastric Function in Chronic Atrophic Gastritis By Using L-Cysteine: A 3 Years Study (2017) (1)
Sa1408 Predictive Value of the “DICA” Endoscopic Classification on the Outcome of Diverticular Disease of the Colon: An International Study (2016) (1)
Failure of drugs acting on H2-receptors to modify plasma prolactin levels in pituitary adenomas: evidence for a suprapituitary locus of action. (1981) (1)
P.02.9: Prevalence of Atrophic Gastritis in General Population: A Gastropanel®-Based Study, Compared with Olga Histological Classification (2017) (1)
307 Rifaximin for Prevention of NSAID-Associated Intestinal Lesions in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Video-Capsule Study (2015) (1)
Cancer Prevention in Patients with GERD and Barrett’s Esophagus—Medicine (2021) (1)
Author Correction: Colonic diverticular disease (2020) (1)
PC.01.2 PREDICTIVE VALUE OF THE “DICA” ENDOSCOPIC CLASSIFICATION ON THE OUTCOME OF THE DIVERTICULAR DISEASE OF THE COLON: AN INTERNATIONAL STUDY (2016) (1)
15 Altered Adenosine Signalling in the Presence of Bowel Inflammation: Role of a2B Receptors in the Control of Colonic Motility (2012) (1)
Impaired TSH response to TRH after intravenous ranitidine in man (1983) (1)
Pharmacologic treatment of GERD in adolescents: Is esophageal mucosal protection an option? (2022) (1)
Effects of Bombesin on Gastric Emptying of Solids in Normal and Antrectomized Subjects: Evidence for an Action at the Distal Stomach (1984) (1)
Effect of CCK-receptor antagonists on gastric emptying (1993) (1)
[Further observations of the inhibitory effect of the disodium salt of 9-hydroxy-8,12-trans-19,20-bis-norprostanoic acid (rosaprostol) on gastric secretion]. (1984) (1)
Su1203: NOVEL APPROACH TO EVALUATE THE IMPACT OF MODERATE AND STRONG CYP3A INDUCERS ON VONOPRAZAN EXPOSURE (2022) (1)
Medical Management of Dumping Syndrome: The Place of Octreotide (1996) (1)
Su1349 Predictive Value of the “DICA” Endoscopic Classification on the Outcome of the Diverticular Disease of the Colon (2015) (1)
4: PROTECTIVE EFFECTS OF ESOXX™ ONE, A HYALURONIC ACIDCHONDROITIN SULPHATE BASED MUCOADHESIVE FORMULATION ON 3D RECONSTRUCTED HUMAN ESOPHAGEAL EPITHELIUM (2022) (1)
Preface to the Proceedings of the 2nd International Symposium on Diverticular Disease of the Colon. (2016) (1)
S1387 A Population Pharmacokinetic Model of Vonoprazan: Evaluating the Effects of Race and Disease Status on Exposure (2021) (1)
M1260 Effect of Cyclically Long-Term Treatment With Mesalamine in Patients With Symptomatic Uncomplicated Diverticular Disease (SUDD): A 5 Years Follow-up Study (2010) (1)
The Management of Nonvariceal Upper Digestive Bleeding: Is There a Role for Somatostatin and Its Analogues? (1996) (1)
Inhibition of gastric emptying by angiotensin in the rat and its antagonism by saralasin. (1983) (1)
Acid-Lowering Drugs in the Treatment of Gastroesophageal Reflux Disease: An Overview (1992) (1)
Su1205: A CLINICAL DRUG INTERACTION STUDY TO ASSESS THE EFFECT OF VONOPRAZAN ON THE PHARMACOKINETICS OF MIDAZOLAM (2022) (1)
Functional Ultrasonography of the Digestive Tract (1997) (1)
P.26 DIAGNOSTIC ACCURACY OF SERUM PEPSINOGENS AND GASTRIN IN THE FOLLOW-UP OF HELICOBACTER PYLORI INFECTION: A PILOT STUDY (2010) (1)
Sa1976 GastroPanel and OLGA: Two Innovative Tools for the Detection of Atrophic Gastritis. A Prospective Study in Primary Care (2013) (1)
Course of the Diverticular Disease: What is changing? (2020) (1)
NSAID-induced gastroduodenal damage : prevention and treatment (1995) (1)
The Place of Octreotide in the Medical Management of Neuroendocrine Gut Tumors (1996) (1)
Plasma levels and renal removal of gastrin after acute hepatic ischemia in dogs (1984) (1)
OC.05.4 CARDIAC SAFETY OF PRUCALOPRIDE IN RANDOMIZED CLINICAL TRIALS OF PATIENTS WITH CHRONIC CONSTIPATION (2014) (1)
PA.6 GASTRIN-17 (G-17): A SEROLOGICAL BIO-MARKER FOR DIAGNOSIS OF GASTRO-ESOPHAGEAL REFLUX DISEASE (GERD) (2008) (1)
Sa1988 Recovery of Gastric Function After Helicobacter pylori Eradication and Acetium Administration: A 6 Years Study in Atrophic Gastritis Subjects (2013) (1)
P.06.23 EARLY GERD RELAPSE: A PROSPECTIVE ONE YEAR STUDY BY MEANS OF A NON-INVASIVE SURROGATE TEST (2018) (1)
Bombesin: An insulinotropic peptide in humans (1987) (1)
Traveler's Diarrhea: Recent Advances (1995) (1)
P.02.7: The Branded Proton Pump Inhibitors (PPIS) Increase Levels of Gastrin 17 (G-17) More than the Generic Ones in Dyspeptic Patients from an Italian Primary Care Population (2017) (0)
Preface (2001) (0)
Caerulein affects gonadotropin secretion in humans. (1981) (0)
T1979 Pepsinogen II As Marker of Inflammation in H.P Infection and in NSAIDs Damage (2009) (0)
Sa2022 Does Prucalopride Have a Pro-Arrhythmic Potential? Lessons From Randomized Clinical Trials in Chronic Constipation (2014) (0)
Efficacy of Rifaximin to Eradicate Small Intestine Bacterial Overgrowth and to Get Symptom Relief: A Systematic Review and Meta-Analysis: 1176 (2017) (0)
NSAID-Induced Gastroduodenal Damage. Prevention and Treatment: Round Table at the 2nd Congress of the Mediterranean Society of Clinical Pharmacology. 9th National Congress of the Italian Society of Clinical Pharmacology, Venice, October 1991: Proceedings (1995) (0)
P.09.2 IS H. PYLORI ERADICATION USEFUL IN THE IMPROVEMENT OF DYSPEPSIA? A 15 YEARS STUDY (2013) (0)
P.09.19 GASTROPANEL AND OLGA: TWO INNOVATIVE TOOLS FOR THE DETECTION OF ATROPHIC GASTRITIS. A PROSPECTIVE STUDY IN PRIMARY CARE (2013) (0)
P.04.10 LOW LEVELS OF GASTRIN-17 AS A NON-INVASIVE MARKER OF GERD (2013) (0)
[Ranitidine inhibits pancreatic secretion and growth stimulated by caerulein]. (1984) (0)
960 Colonic Dysmotility Associated With High Fat Diet-Induced Obesity: Involvement of Endogenous Adenosine via a2B Receptors (2015) (0)
A translational pharmacokinetic/pharmacodynamic approach supports optimal vonoprazan dosing for erosive oesophagitis and Helicobacter pylori infection. (2023) (0)
[Effect of octylonium bromide on the gastrointestinal tract in vivo]. (1980) (0)
[Effect of cimetidine on acute experimental pancreatitis in the rat]. (1981) (0)
Esophageal mucosal defence recent advances : proceedings of a symposium during the 4th international OESO congress, Paris, September 1-4, 1993 ; 11 tables (1995) (0)
M1261 Recurrence of Diverticulitis in Patients With Symptomatic Uncomplicated Diverticular Disease (SUDD) Treated Cyclically With Mesalamine: Result of a Follow-up Study (2010) (0)
Tu1834 Low Levels of Gastrin-17 As a Non-Invasive Marker of GERD (2013) (0)
S1388 Vonoprazan-based Dual Therapy and Vonoprazan-based Triple Therapy for H. pylori Eradication: A Comparison of the Available Data (2021) (0)
Measuring gastric drainage of liquids in the rats (1983) (0)
Su1193 Rifaximin Prevents Enteric Bacteria Alterations and Inflammation in a Rat Model of Diclofenac-Induced Enteropathy (2016) (0)
P.04.9 DIAGNOSIS OF CHRONIC ATROPHIC GASTRITIS IN PRIMARY CARE SETTING BY MEANS OF GASTROPANEL®: A POPULATION STUDY ON 10,000 CONSECUTIVE PATIENTS (2016) (0)
Esophageal Mucosal Defence: Recent Advances (1995) (0)
Flow-cytometric DNA/protein content variation, p53 overexpression and Ki67 levels in Barrett's esophagus (2000) (0)
Constant Increase in Primary Resistances of Helicobacter pylori strains and Their Role in the Effectiveness of Sequential Therapy: A Lesson From a 5-Year Study: 1211 (2017) (0)
Subject Index, Vol 31, 1985 (1985) (0)
Therapeutic Strategy in Gastro-oesophageal Reflux Disease (1993) (0)
Su1423 Eradication of Small Intestine Bacterial Overgrowth With Rifaximin: A Doseand Time-Dependent Effect (2014) (0)
Subject Index, Vol. 8, Supplement 1, 1990 (1990) (0)
Preliminary Pages / Contents / Preface to the Updated Reprint / Foreword / Preface (2004) (0)
THE NATURAL HISTORY OF GASTRIC ULCER: A TWENTY-FOUR YEARS CLINICAL-ENDOSCOPICAL FOLLOW-UP (2009) (0)
Subject Index Vol. 15, Supplement 1, 1997 (1997) (0)
Rifaximin prevents diclofenac-induced enteropathy in rats through antibacterial and anti-inflammatory activities (2018) (0)
Subject Index, Vol. 41, 1988 (1988) (0)
Ultrasonography in the Functional Evaluation of Upper Digestive Tract (1994) (0)
P.02.18: Non Invasive Diagnosis of Upper Gi Diseases in a Primary Care Setting: A Study on 1,900 Patients (2017) (0)
AF.2 A NATIONAL SURVEY OF UPPER GASTROINTESTINAL SYMPTOMS IN PATIENTS ATTENDING GASTROENTEROLOGY CLINICS OF THE ITALIAN NHS: AN INTERIM ANALYSIS OF THE GUESS STUDY (2021) (0)
Tiered approach to evaluate the CYP3A victim and perpetrator drug–drug interaction potential for vonoprazan using PBPK modeling and clinical data to inform labeling (2023) (0)
Management of Esophageal Varices: Pharmacological, Endoscopic and Surgical Approach (1992) (0)
P.01.11: Gastrin 17 in Singling out Patients with Different Pattern of Gastroesophageal Reflux: A Pilot Study using PH-Impedance as Reference Standard (2017) (0)
P.1.288: PEPSINOGEN I, II, RATIO, AND G-17 IN PATIENTS WITH ESOPHAGITIS AND PATIENTS WITH EXTRA-ESOPHAGEAL MANIFESTATIONS OF GERD (2011) (0)
P.07.2: Natural History of Symptomatic Uncomplicated Diverticular Disease: A 13-Year Prospective Study (2017) (0)
T1651 The Natural History of Gastric Ulcer: A Twenty-Four Years Clinical-Endoscopical Follow-Up (2009) (0)
Unspecified Intestinal Malabsorption Associated with Angiotensin Receptor Blocker Therapy: Results from a Nationwide, Population-Based Study in Italy and Germany (2016) (0)
Contents, Vol. 15, 1981 (1981) (0)
PA.28 SERUM PEPSINOGEN I AS NON INVASIVE MARKER OF GASTRIC ACID SECRETION (2008) (0)
Pepsinogen I, II, Ratio, and G-17 in Patients With Esophagitis and Patients With Extra-Esophageal Manifestations of GERD (2011) (0)
Some evidence for central A2 receptors that inhibit acid secretion in the rat (1989) (0)
Contents, Vol 31, 1985 (1985) (0)
P.06.30 RISK FACTORS FOR ONSET OF ESOPHAGITIS IN A LONG 15 YEARS FOLLOW-UP (2018) (0)
[Effect of the stimulation of H2 receptors by impromidine in patients with idiopathic dilated cardiomyopathy]. (1987) (0)
P022 Role of P2X7 purinergic receptor in the control of enteric neuromuscular functions in normal rat distal colon and experimental bowel inflammation (2014) (0)
Subject Index, Vol. 24, 1986 (1986) (0)
M1804 Pharmacist Attitudes About Constipation and Its Treatment: A Survey Conducted in Three Countries (2008) (0)
P.09.23 OVERLAP OF THREE PATHOLOGICAL CONDITIONS (HELICOBACTER PYLORI INFECTION, YELLOW STOMACH AND LACTOSE INTOLERANCE) IN PATIENTS WITH GASTROINTESTINAL DISORDERS (2013) (0)
50 - Reflux Esophagitis after Helicobacter Pylori Eradication: The Role of Gastric Acid Secretion (2018) (0)
Preface (2006) (0)
[Helicobacter pylori infection: relationships between gastritis and clinical symptomatology]. (1996) (0)
P.01.12 FREQUENCY OF DIAGNOSIS OF ATROPHIC GASTRITIS IN A PRIMARY CARE SETTING: A POPULATION STUDY ON 10,000 PEOPLE (2018) (0)
P.01.5: Serum Pepsinogen II as a Non-Invasive Marker for Diagnosis of Helicobacter Pylori Infection: A Prospective Study in a Cohort of Dyspeptic Patients (2017) (0)
Ranitidine inhibits the trophic effect of caerulein on the pancreas in rats (preliminary data). (1984) (0)
Sa1862 Are All Patients With Histological Diagnosis of Atrophic Gastritis Really At Risk of Developing Gastric Cancer? Assessment of Gastric Acid Production by Correlation Between Maximal Acid Output and Pepsinogen I (2014) (0)
OC.09.2: Appropriateness of PPI Administration in the Elderly: Evaluation of Acid Secretion and Atrophic Gastritis by Means of a Non-Invasive Test (2017) (0)
[Spasmolytic effect of octylonium bromide on gastrointestinal motility in vitro]. (1980) (0)
OC.07.3 RECOVERY OF GASTRIC FUNCTION AFTER ACETIUM® ADMINISTRATION: A 2 YEAR PROSPECTIVE STUDY IN PATIENTS WITH CHRONIC, ATROPHIC, BODY GASTRITIS (2016) (0)
P.29 USEFULNESS OF NON INVASIVE TEST (GASTROPANEL) FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASE (2010) (0)
[Effect of benzquinamide on gastrointestinal motility]. (1980) (0)
P.05.11 CLINICAL USEFULNESS OF LACTOSE-RESTRICTED DIET IN POSITIVE QUICK LACTASE TEST PATIENTS: PROSPECTIVE 4 MONTHS STUDY (2013) (0)
Title Page / Table of Contents / Foreword / Preface (2005) (0)
P.02.8: Chronic Atrophic Gastritis is Related with an Increased Risk for Cardiovascular Diseases, Assessed by Homocysteine Serum Levels Determination (2017) (0)
Recent Advances in Gastrointestinal Pharmacology And Therapeutics (2006) (0)
Contents, Vol. 56, Supplement 1, 1995 (1995) (0)
Can one specify unequivocal indications for pH measurement (1994) (0)
[Modalities and diagnostic criteria in esophageal ph monitoring]. (1999) (0)
Author Index / Subject Index, Vol. 13, 1995 (1995) (0)
OC.18.1 ARE ALL PATIENTS WITH HISTOLOGICAL DIAGNOSIS OF ATROPHIC GASTRITIS REALLY AT RISK OF DEVELOPING GASTRIC CANCER? ASSESSMENT OF GASTRIC ACID PRODUCTION BY CORRELATION BETWEEN MAXIMAL ACID OUTPUT AND PEPSINOGEN I (2014) (0)
Is proton pump inhibitor therapy always needed in the elderly (2015) (0)
Su1191 Efficacy of Sequential Therapy for Eradication of Helicobacter pylori All Over the Word. Lessons From a Comparative Meta-Analysis (2014) (0)
P.04.11 A NEW APPROACH TO DETECTION OF NON-RESPONDER PATIENTS IN GERD BY NON-INVASIVE MARKERS (2013) (0)
T1082 Eradication Rate of Helicobacter pylori in Immigrant Patients Compared to Italian Patients: Results of a Clinical Trial (2010) (0)
Effects of bombesin on the pituitary response to TRH and LHRH in humans (1984) (0)
Reviewer ' s report Title : Early effects of oral administration of lafutidine with mosapride compared with lafutidine alone on intragastric pH values (0)
What is the pH measurement profile in patients with CLE (1994) (0)
P.02.1: Individual Assessment of Gastric Acid Production by Means of a Non-Invasive Test: Relationship Between Maximal Acid Output and Serum Pepsinogen I Levels in Patients with Different Upper GI Diseases (2017) (0)
[Medical treatment of gastroesophageal reflux by H2 receptor antagonists]. (1999) (0)
P.10 “GASTROPANEL TEST” IN THE CLINICAL OUTCOME OF GERD: PROSPECTIVE SIX MONTHS CLINICAL STUDY (2010) (0)
Rifaximin: A Poorly Absorbed Antibiotic: Pharmacology and Clinical Use Supplement Issue: 'Chemotherapy 2005, Vol. 51, Suppl. 1' (2005) (0)
P.1.193: MESALAMINE FOR THE MANAGEMENT OF PATIENTS WITH UNCOMPLICATED DIVERTICULAR DISEASE (SUDD): A 24 MONTHS PROSPECTIVE FOLLOW-UP STUDY (2011) (0)
Contents, Vol. 41, Supplement 1,1995 (1995) (0)
T1977 Rand Appropriateness Study with Development of Recommendations for NSAID Treatment (2009) (0)
P.01.22 REFLUX ESOPHAGITIS AFTER H.P. ERADICATION: THE ROLE OF GASTRIC ACID SECRETION (2018) (0)
Title Page / Contents / Foreword / Preface (1996) (0)
[Role of the vagus nerve on the insulin-stimulating effect of pentagastrin. I. Effect of atropine in the dog]. (1974) (0)
Acknowledgement to reviewers (2017) (0)
Tu1825 A New Approach to Detection of Non-Responder Patients in GERD by Non-Invasive Markers (2013) (0)
Individual Assessment of Gastric Acid Production by Means of a Non-Invasive Test: Relationship between Maximal Acid Output and Pepsinogen I Levels (2017) (0)
P.09.22 GASTROPANEL, A NON-INVASIVE, SAFE ENDOSCOPY METHOD: A PROSPECTIVE 1000 PATIENTS STUDY IN PRIMARY CARE SETTING (2013) (0)
P.02.2: Improvement of Symptoms in Patients Affected by Chronic Athrophic Gastritis: A 2 Years Prospective Study by using L-Cysteine (Acetium™) (2017) (0)
P.18.7 DOSE- AND TIME-DEPENDENT ERADICATION OF SMALL INTESTINE BACTERIAL OVERGROWTH (SIBO) WITH RIFAXIMIN: A META-ANALYTIC APPROACH (2014) (0)
Effect of nizatidine on salivary secretion in the rat (1992) (0)
P.1.325: USEFULNESS OF SERUM PEPSINOGENS TO IDENTIFY CHRONIC ATROP H IC GASTRITIS (2011) (0)
M1262 Baseline Symptoms in Patients With Symptomatic Uncomplicated Diverticular Disease (SUDD) (2010) (0)
OC.05.3 HOW CAN WE MEASURE ACID SECRETION IN THE SINGLE PATIENT? A VALIDATED NON-INVASIVE SURROGATE TEST COMPARED WITH MAXIMAL ACID OUTPUT IN 600 PEOPLE (2018) (0)
Drug therapy of gastro-oesophageal reflux disease (2019) (0)
W1079 Curcumin Vs Domperidon in Functional Dyspepsia: Better the Prokinetic or An Agonist of Vanilloid Receptor? (2008) (0)
Colonic motor dysfunctions in a mouse model of high-fat diet-induced obesity: an involvement of A2B adenosine receptors (2017) (0)
Author lndex Vol. 12, 1994 (1994) (0)
P.12.12 INTERMITTENT VERSUS EVERY-DAY MESALAZINE THERAPY IN PREVENTING COMPLICATIONS OF DIVERTICULAR DISEASE OF THE COLON: A LONG-TERM FOLLOW-UP STUDY (2013) (0)
Non-invasive assessment of gastric secretory function in centenarians (2017) (0)
P.09.6 SEQUENTIAL THERAPY FOR HELICOBACTER PYLORI IN CHILDREN: A SYSTEMATIC REVIEW AND META-ANALYSIS (2013) (0)
Selective Antimuscarinic Compounds: Is There a Place in the Treatment of Gastroesophageal Reflux Disease? (1992) (0)
Is synthesis of nitric oxide altered in gastroesophageal junction (1998) (0)
Title Page / Dedication / Contents / Foreword / Preface (1994) (0)
Author and Subject Index (1999) (0)
P.01.7: Efficacy of PPIS and H-2 Blockers Therapy on Acid Suppression Assessed by Gastrin-17 and Pepsinogen I Serum Levels Determination in Gerd Patients (2017) (0)
Consensus Conference: Coxibs in the Management of Osteoarthritis. (2003) (0)
OC.02.5 SEQUENTIAL THERAPY FOR HELICOBACTER PYLORI: STILL FAR FROM THE IDEAL TREATMENT – A SYSTEMATIC REVIEW AND META-ANALYSIS (2013) (0)
The author replies (2002) (0)
Tu1315 - Is the Interval Between the first and the Second H.P. Eradication Therapy Relevant for the Success of the Cure? A Comparison Between One Week, One Month and One Year (2018) (0)
Esomeprazole-Based Regimens for Helicobacter pylori Eradication (Updated Contents) (2004) (0)
Su1200 - Environmental Factors (Divorce, Job Changing, Night Shift Change): Critical Role in IBS Outcome. A Study on 110 Consecutive Patients (2018) (0)
Erratum to: New therapeutic approaches for management of sport-induced muscle strains (2010) (0)
OC.03.3 THE “DICA” ENDOSCOPIC CLASSIFICATION FOR DIVERTICULAR DISEASE OF THE COLON SHOWS A SIGNIFICANT INTEROBSERVER AGREEMENT AMONG COMMUNITY ENDOSCOPISTS (2019) (0)
M1236 Prevalence of Self-Defined Constipation and Laxative Use Among Adults from South America and Asia (2009) (0)
Gastroesophageal reflux disease and pH monitoring (1990) (0)
P.06.26 RISK FACTORS IN GERD: A COMPARATIVE STUDY WITH DYSPEPTIC SUBJECTS ON 2300 PEOPLE IN A PRIMARY CARE SETTING (2018) (0)
Subject lndex Vol. 12, 1994 (1994) (0)
P.01.14: Overweight and Obesity as Risk Factors for Gerd Outcome: A 10 Years Study on a Gerd Population of 365 Patients (2017) (0)
23(rd) UEG Week 2015: Barcelona, Spain, October 2015. (2015) (0)
Subject Index, Vol. 10, Supplement 1, 1992 (1992) (0)
Mo1953 “SCORE” for Cardiovascular Risk: A Tool for Screening to Detect High Risk of Colorectal Neoplasia (2015) (0)
Tu1640 - The Clinical Outcome of Sudd: A 15-Years Prospective Study (2018) (0)
Long-Term Intragastric pH Measurement in Man: Basic and Methodological Aspects International Workshop, London, September 1987: Selected Papers (1990) (0)
P.06.13 PRUCALOPRIDE FOR SEVERE COSTIPATION, HOW TO REACH THE SYMPTOM RESOLUTION AND HAVE TO MAINTAIN IT: A SIX-MONTHS EXPERIENCE (2013) (0)
Su1951 Recovery of Gastric Function After Acetium Administration: A 6 Months Study in Atrophic Gastritis Subjects (2014) (0)
New Therapeutic Approaches for Management of Sport-Induced Muscle Strains (vol 26, pg 1072, 2009) (2010) (0)
[Protective effect of ranitidine in acute experimental pancreatitis in the rat]. (1983) (0)
Correction to: Acid Suppressant Therapy: a Step Forward with Potassium-Competitive Acid Blockers (2021) (0)
Contents, Vol. 41, 1988 (1988) (0)
PREVENTION AND TREATMENT OF NSAID-INDUCED GASTRO-DUODENAL DAMAGE : RATIONALE FOR THE USE OF ANTISECRETORY COMPOUNDS (1999) (0)
OC3.07.1 CURCUMIN VS DOMPERIDON IN FUNCTIONAL DYSPEPSIA: BETTER THE PROKINETIC OR AN AGONIST OF VANILLOID RECEPTOR? (2008) (0)
Mo1194 - Natural History of Gastric Ulcer in a 25 Years Follow-Up: Role of Helicobacter Pylori Infection and Nonsteroidal Anti-Inflammatory Drugs (2018) (0)
Non Invasive Diagnosis of Upper GI Diseases in a Primary Care Setting: A Study on 1,900 Patients (2017) (0)
M1141 Diagnostic Accuracy of Serum Pepsinogens and Gastrin to Follow-up Helicobacter pylori Infection: A Pilot Study (2010) (0)
Role of A2B receptors in the control of colonic cholinergic motility in the presence of bowel inflammation (2012) (0)
398 Rifaximin Displays a Protective Activity in Experimental Enteropathy Induced by Indomethacin in Rats (2015) (0)
Profile of the candidate for medical treatment. (1996) (0)
OC.06.5 IS SEQUENTIAL THERAPY FOR ERADICATION OF HELICOBACTER PYLORI EQUALLY EFFECTIVE ALL OVER THE WORLD? A META-ANALYTIC APPROACH (2014) (0)
What is the frequency of the progression of diffuse esophageal spasm towards achalasia (1998) (0)
H2 Receptor Antagonists: Is There a Place in the Treatment of Helicobacter pylori Infection? (1994) (0)
Contents Vol. 12, 1994 (1994) (0)
Somatostatin Analogs in Cancer Management (2001) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Carmelo Scarpignato?

Carmelo Scarpignato is affiliated with the following schools:

Carmelo Scarpignato's Academic­Influence.com Rankings

Why Is Carmelo Scarpignato Influential?

Carmelo Scarpignato's Published Works

Published Works

What Schools Are Affiliated With Carmelo Scarpignato?

Carmelo Scarpignato's AcademicInfluence.com Rankings